{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:31:56Z","timestamp":1782880316494,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dld.2025.11.012","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:32:34Z","timestamp":1766233954000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparing the efficacy and safety of medications to prevent nonsteroidal anti-inflammatory drug-induced ulcers in high-risk patients: A network meta-analysis"],"prefix":"10.1016","volume":"58","author":[{"given":"Xu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-4447","authenticated-orcid":false,"given":"Dongmei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2025.11.012_bib0001","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gtc.2010.08.010","article-title":"Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention","volume":"39","author":"Scarpignato","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.dld.2025.11.012_bib0002","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jama.2020.22171","article-title":"Diagnosis and treatment of hip and knee osteoarthritis: A review","volume":"325","author":"Katz","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.dld.2025.11.012_bib0003","first-page":"728","article-title":"Practice Parameters Committee of the American College of G. Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.11.012_bib0004","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/jpet.111.185314","article-title":"Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438)","volume":"339","author":"Shin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2025.11.012_bib0005","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/gutjnl-2017-314010","article-title":"Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study","volume":"67","author":"Mizokami","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.11.012_bib0006","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(16)32404-7","article-title":"Peptic ulcer disease","volume":"390","author":"Lanas","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2025.11.012_bib0007","doi-asserted-by":"crossref","first-page":"707","DOI":"10.5009\/gnl20246","article-title":"Clinical Guidelines for drug-related peptic ulcer, 2020 revised edition","volume":"14","author":"Joo","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.dld.2025.11.012_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.dld.2025.11.012_bib0009","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata","volume":"39","author":"Shim","year":"2017","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.dld.2025.11.012_bib0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jclinepi.2016.02.016","article-title":"The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes","volume":"76","author":"Veroniki","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2025.11.012_bib0011","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/gutjnl-2017-314852","article-title":"Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study","volume":"67","author":"Kawai","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.11.012_bib0012","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2009.09.063","article-title":"Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions","volume":"138","author":"Ng","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.11.012_bib0013","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2016.09.006","article-title":"Similar efficacy of proton-pump inhibitors vs H2-receptor antagonists in reducing risk of upper gastrointestinal bleeding or ulcers in high-risk users of low-dose aspirin","volume":"152","author":"Chan","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.11.012_bib0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JCMA.0000000000000465","article-title":"Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial","volume":"84","author":"Tseng","year":"2021","journal-title":"J Chin Med Assoc: JCMA"},{"key":"10.1016\/j.dld.2025.11.012_bib0015","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.amjmed.2005.04.031","article-title":"Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications","volume":"118","author":"Lai","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2025.11.012_bib0016","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.gastro.2004.07.010","article-title":"Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial","volume":"127","author":"Chan","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.11.012_bib0017","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2025.11.012_bib0018","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2025.11.012_bib0019","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/gutjnl-2013-304722","article-title":"Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study","volume":"63","author":"Sugano","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.11.012_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2036.2012.05133.x","article-title":"Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients","volume":"36","author":"Sugano","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.11.012_bib0021","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.11.012_bib0022","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.2.169","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole","volume":"162","author":"Graham","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2025.11.012_bib0023","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.12907","article-title":"Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin","volume":"40","author":"Iwakiri","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.11.012_bib0024","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00535-011-0397-7","article-title":"Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial","volume":"46","author":"Sugano","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2025.11.012_bib0025","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00535-012-0588-x","article-title":"Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial","volume":"47","author":"Sanuki","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2025.11.012_bib0026","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","article-title":"Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial","volume":"369","author":"Chan","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2025.11.012_bib0027","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/S0140-6736(17)30981-9","article-title":"Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial","volume":"389","author":"Chan","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2025.11.012_bib0028","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1053\/gast.1997.v112.pm9178671","article-title":"Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration","volume":"112","author":"Hudson","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.11.012_bib0029","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.0953-0673.1996.00347.x","article-title":"High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs","volume":"10","author":"ten Wolde","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.11.012_bib0030","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/BF02064210","article-title":"Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers. A one-year study","volume":"40","author":"Agrawal","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2025.11.012_bib0031","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/apt.13642","article-title":"Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity","volume":"43","author":"Yuan","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.11.012_bib0032","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2024.19094","article-title":"Peptic Ulcer Disease: A review","volume":"332","author":"Vakil","year":"2024","journal-title":"Jama"},{"key":"10.1016\/j.dld.2025.11.012_bib0033","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1253\/circj.CJ-22-0127","article-title":"Cost-effectiveness of Vonoprazan compared with proton pump inhibitors in patients taking low-dose aspirin for secondary prevention of cardiovascular events in Japan","volume":"87","author":"Ishii","year":"2023","journal-title":"Circ j: off j Jpn Circ Soc"},{"key":"10.1016\/j.dld.2025.11.012_bib0034","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.therap.2020.06.019","article-title":"Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations","volume":"76","author":"Koyyada","year":"2021","journal-title":"Therapie"},{"key":"10.1016\/j.dld.2025.11.012_bib0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/joim.13505","article-title":"Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials","volume":"292","author":"Stiller","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.dld.2025.11.012_bib0036","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825012113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825012113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:31:37Z","timestamp":1769085097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825012113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1590865825012113"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.11.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the efficacy and safety of medications to prevent nonsteroidal anti-inflammatory drug-induced ulcers in high-risk patients: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}